Hudock, Inc. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 171 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.

Quarter-by-quarter ownership
Hudock, Inc. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$10,000
-33.3%
2,200
+120.0%
0.00%
-57.1%
Q4 2014$15,000
+36.4%
1,0000.0%0.01%0.0%
Q3 2014$11,000
-26.7%
1,0000.0%0.01%
-58.8%
Q2 2014$15,000
-16.7%
1,0000.0%0.02%
+13.3%
Q1 2014$18,000
+28.6%
1,0000.0%0.02%
+25.0%
Q4 2013$14,000
+40.0%
1,0000.0%0.01%
+20.0%
Q3 2013$10,000
+25.0%
1,0000.0%0.01%
-16.7%
Q2 2013$8,0001,0000.01%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,400,000$12,320,0004.56%
EcoR1 Capital, LLC 2,568,119$22,599,0004.01%
FIC CAPITAL INC 960,338$8,451,0003.48%
Opaleye Management Inc. 580,000$5,104,0002.13%
DAFNA Capital Management LLC 225,000$1,980,0001.41%
RA Capital Management 1,250,000$11,000,0001.26%
Iguana Healthcare Management, LLC 215,000$1,892,0001.07%
Avoro Capital Advisors LLC 800,000$7,040,0000.89%
WASATCH ADVISORS LP 6,930,535$60,989,0000.85%
Cormorant Asset Management, LP 400,000$3,520,0000.58%
View complete list of SANGAMO THERAPEUTICS INC shareholders